Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Adenocarcinoma”

1,161 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,161 results

Not applicableActive Not RecruitingNCT02874885
What this trial is testing

Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal AdenocarcinomaMetastatic Rectal AdenocarcinomaRectosigmoid Adenocarcinoma+10 more
M.D. Anderson Cancer Center 341
Not applicableStudy completedNCT02454647
What this trial is testing

Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients

Who this might be right for
Gastric CancerAdenocarcinomaEffects of Chemotherapy+2 more
Clinica Universidad de Navarra, Universidad de Navarra 46
Large-scale testing (Phase 3)UnknownNCT02409199
What this trial is testing

Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer

Who this might be right for
Gastric Carcinoma
Shanghai Zhongshan Hospital 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243938
What this trial is testing

Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)

Who this might be right for
Locally Advanced Rectal Cancer (LARC)Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal Cancer (mCRC)+1 more
Tao Zhang 70
Large-scale testing (Phase 3)UnknownNCT01126138
What this trial is testing

Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)

Who this might be right for
Carcinoma, Invasive Ductal, Breast
Chinese Academy of Medical Sciences 200
Testing effectiveness (Phase 2)UnknownNCT03961698
What this trial is testing

Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma

Who this might be right for
Breast CancerRenal Cell Carcinoma
Infinity Pharmaceuticals, Inc. 91
Early research (Phase 1)Study completedNCT01711515
What this trial is testing

Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+6 more
National Cancer Institute (NCI) 34
Early research (Phase 1)Looking for participantsNCT06066138
What this trial is testing

Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Who this might be right for
Locally Advanced Alveolar Soft Part SarcomaMetastatic Alveolar Soft Part SarcomaLocally Advanced Non Small Cell Lung Cancer+7 more
National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Study completedNCT00924989
What this trial is testing

OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Astellas Pharma Inc 139
Testing effectiveness (Phase 2)Looking for participantsNCT04570943
What this trial is testing

Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
Institut du Cancer de Montpellier - Val d'Aurelle 103
Testing effectiveness (Phase 2)Study completedNCT00268840
What this trial is testing

The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer

Who this might be right for
Pancreatic NeoplasmsBiliary Tract Neoplasms
ARCAGY/ GINECO GROUP 45
Large-scale testing (Phase 3)Active Not RecruitingNCT05043090
What this trial is testing

Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC

Who this might be right for
Papillary Renal Cell Carcinoma
AstraZeneca 148
Not applicableLooking for participantsNCT06846996
What this trial is testing

Real-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in China

Who this might be right for
HER2-positive Gastric CancerHER2-positive Gastroesophageal Junction
Daiichi Sankyo 260
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Not applicableNot Yet RecruitingNCT06272162
What this trial is testing

Locally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided Radiotherapy

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
UMC Utrecht 150
Testing effectiveness (Phase 2)Study completedNCT02199418
What this trial is testing

Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Ductal Breast Cancer+1 more
RenJi Hospital 132
Testing effectiveness (Phase 2)UnknownNCT05918419
What this trial is testing

Efficacy and Safety of Neoadjuvant Chemoradiation Plus Serplulimab in Patients With Locally Advanced Adenocarcinoma of Gastroesophageal Junction

Who this might be right for
Gastroesophageal Junction Adenocarcinoma
Peking Union Medical College Hospital 35
Testing effectiveness (Phase 2)UnknownNCT03288350
What this trial is testing

MDCF + Avelumab in Resectable Esophago-gastric Adenocarcinoma (EGA)

Who this might be right for
Gastric AdenocarcinomaEsophageal Adenocarcinoma
McGill University Health Centre/Research Institute of the McGill University Health Centre 55
Post-approval studies (Phase 4)Study completedNCT01496313
What this trial is testing

To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer

Who this might be right for
Thyroid Cancer
Sanofi 81
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07050524
What this trial is testing

Omega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II Trial

Who this might be right for
Gastric Cancer Stage III
The First Affiliated Hospital with Nanjing Medical University 80
Load More Results